首页> 外文会议>Research, Invention, and Innovation Congress >Compatibility between Magnesium Stearate and Pharmaceutical Acidic Active Compounds/Excipients with DSC
【24h】

Compatibility between Magnesium Stearate and Pharmaceutical Acidic Active Compounds/Excipients with DSC

机译:硬脂酸镁与药物酸性活性化合物/赋形剂与DSC之间的相容性

获取原文

摘要

Compatibility investigation was performed between magnesium stearate and acidic drug compounds (ibuprofen, indomethacin and valproic acid) and acidic pharmaceutical excipients (lactic acid and citric acid) using differential scanning calorimetry (DSC). DSC study indicated the possible incompatibility for the mixture between magnesium stearate and any compounds. Alteration in DSC thermogram was found in all mixtures. The eutectic phenomenon was found in the powder mixture of magnesium stearate and ibuprofen. In addition, the presence of melting endothermic peak of stearic acid in other powder mixtures except the mixture of magnesium stearate and indomethacin indicating breakage of salt form of magnesium stearate. This alteration could relate to the influence on physicochemical properties of drug compounds and pharmaceutical excipients which powder x-ray diffraction (PXRD) and Fourier Transform Infrared Spectroscopy (FT-IR) should be further analyzed to confirm the interactions between compounds.
机译:使用差示扫描量热法(DSC)在硬脂酸镁和酸性药物化合物(布洛芬,吲哚美辛和丙戊酸)和酸性药物赋形剂(乳酸和柠檬酸)之间进行相容性研究。 DSC研究表明了硬脂酸镁和任何化合物之间的混合物可能的不相容性。在所有混合物中发现了DSC热分析图的改变。在硬脂酸镁和布洛芬的镁的粉末混合物中发现了共晶现象。此外,除了镁硬脂酸镁和吲哚美辛的混合物,表明盐形式的镁硬脂酸镁的混合物,存在熔化硬脂酸的熔化的吸热峰。这种改变可以涉及药物化合物和药物赋形剂的影响,其应进一步分析粉末X射线衍射(PXRD)和傅立叶变换红外光谱(FT-IR)以确认化合物之间的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号